An introduction to a full training in psychedelic psychotherapy for clinicians!
About this Event
Join us for a three-hour discussion on how to provide psychedelic psychotherapy in a mental health setting using cannabis and ketamine. Denver-based clinic Innate Path has been testing and providing psychedelic treatment using these readily available or FDA-approved medicines for years. Combined with a non-ordinary state somatic therapy that changes the processing pathway from cognition and insight towards the autonomic nervous system, these medicines generates a clear psychedelic, therapeutically useful response.
Serving as an introduction to a full training in psychedelic psychotherapy for clinicians, this talk:
Discusses the legal and licensing considerations of implementing these medicines into a private practice.
Details a therapeutically useful map of the autonomic nervous system & how the body serves as a processing pathway for psychedelic medicine.
Discusses the transference dynamics of working in psychedelic states
Provides an opportunity to view sample video sessions
Bio:
Saj Razvi is the Director of Education at Innate Path. He was a clinical researcher in the MAPS Phase 2 trial of MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD). His primary focus is on the wide scale adoption and accessibility of psychedelic therapy through training therapists to work with cannabis and ketamine assisted therapy in private practice settings. Saj is fine tuning the Innate Path non-ordinary state somatic psychotherapy model to amplify the effectiveness of psychedelic medicines. He has taught trauma studies as faculty at the University of Denver as well as being a national topic expert for PESI education seminars focusing on complex PTSD. Saj is the primary author of the Innate Path training manual for clinicians and he is part of the program evaluation process taking place at Innate Path to validate the use of cannabis in mental health.